DIFFERENCES IN THE ENTIRE NUCLEOTIDE-SEQUENCE BETWEEN HEPATITIS-B VIRUS GENOMES FROM CARRIERS POSITIVE FOR ANTIBODY TO HEPATITIS-B E-ANTIGEN WITH AND WITHOUT ACTIVE DISEASE

被引:52
作者
HORIKITA, M
ITOH, S
YAMAMOTO, K
SHIBAYAMA, T
TSUDA, F
OKAMOTO, H
机构
[1] JICHI MED SCH,DIV IMMUNOL,MINAMI KAWACHI,TOCHIGI 32904,JAPAN
[2] UNIV TOKUSHIMA,SCH MED,DEPT INTERNAL MED 2,TOKUSHIMA 770,JAPAN
[3] TOKYO METROPOLITAN KOMAGOME HOSP,DEPT INTERNAL MED,TOKYO,JAPAN
关键词
HEPATITIS B VIRUS; HEPATITIS B E ANTIGEN; HEPATITIS ANTIBODIES; FULMINANT HEPATITIS;
D O I
10.1002/jmv.1890440118
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The entire nucleotide sequence was determined for eight hepatitis B virus (HBV) genomes from three symptom-free carriers, two patients with chronic persistent hepatitis and one patient with chronic active hepatitis, who were positive for antibody to hepatitis B e antigen (HBeAg). The two patients with chronic persistent hepatitis were tested again after they developed chronic active or fulminant hepatitis, making a total of eight samples. Six had a point mutation in the preC region prohibiting the encoding of HBeAg precursor, while the remaining two had a deletion of 8 or 21 nucleotides within the X gene upstream of the preC transcription initiation sites which would affect the X gene and the putative preC/C promoter. Most genomes from the three symptom-free carriers and the two patients with chronic persistent hepatitis, with HBV DNA levels of 10(2)-10(3)/ml, had deletion, frameshift mutation, initiation failure or a premature stop codon, rendering them replication-incompetent. In contrast, such mutations were rarely seen in HBV genomes from the two patients with chronic persistent hepatitis after they had developed active or fulminant hepatitis and from the patient with chronic active hepatitis, all of whom had vigorous HBV replication with serum HBV DNA from 10(6) to 10(9)/ml Unique mutations for amino acid changes were more frequent in HBV genomes with a higher replicative activity. These results indicate two kinds of HBV genomes with an HBeAg-minus phenotype, one with defects seriously affecting viral replication and the other without such defects, which would account for different clinical profiles in carriers with antibody to HBeAg. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:96 / 103
页数:8
相关论文
共 36 条
[1]   CHRONIC ACTIVE HEPATITIS WITH HEPATITIS-B VIRUS-DNA AND ANTIBODY AGAINST E-ANTIGEN IN THE SERUM - DISTURBED SYNTHESIS AND SECRETION OF E-ANTIGEN FROM HEPATOCYTES DUE TO A POINT MUTATION IN THE PRECORE REGION [J].
AKAHANE, Y ;
YAMANAKA, T ;
SUZUKI, H ;
SUGAI, Y ;
TSUDA, F ;
YOTSUMOTO, S ;
OMI, S ;
OKAMOTO, H ;
MIYAKAWA, Y ;
MAYUMI, M .
GASTROENTEROLOGY, 1990, 99 (04) :1113-1119
[2]   CHRONIC HEPATITIS IN HBSAG-CARRIERS WITH SERUM HBV-DNA AND ANTI-HBE [J].
BONINO, F ;
ROSINA, F ;
RIZZETTO, M ;
RIZZI, R ;
CHIABERGE, E ;
TARDANICO, R ;
CALLEA, F ;
VERME, G .
GASTROENTEROLOGY, 1986, 90 (05) :1268-1273
[3]   FORMATION OF TRANSMEMBRANEOUS HEPATITIS-B E-ANTIGEN BY COTRANSLATIONAL INVITRO PROCESSING OF THE VIRAL PRECORE PROTEIN [J].
BRUSS, V ;
GERLICH, WH .
VIROLOGY, 1988, 163 (02) :268-275
[4]   VACCINE-INDUCED ESCAPE MUTANT OF HEPATITIS-B VIRUS [J].
CARMAN, WF ;
ZANETTI, AR ;
KARAYIANNIS, P ;
WATERS, J ;
MANZILLO, G ;
TANZI, E ;
ZUCKERMAN, AJ ;
THOMAS, HC .
LANCET, 1990, 336 (8711) :325-329
[5]  
CARMAN WF, 1989, LANCET, V2, P588
[6]  
DEGROOTE J, 1968, LANCET, V2, P626
[7]   VARIATIONS IN CODONS 84-101 IN THE CORE NUCLEOTIDE-SEQUENCE CORRELATE WITH HEPATOCELLULAR INJURY IN CHRONIC HEPATITIS-B VIRUS-INFECTION [J].
EHATA, T ;
OMATA, M ;
YOKOSUKA, O ;
HOSODA, K ;
OHTO, M .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (01) :332-338
[8]   INFECTIOUS HEPATITIS-B VIRUS VARIANT DEFECTIVE IN PRE-S2 PROTEIN EXPRESSION IN A CHRONIC CARRIER [J].
FERNHOLZ, D ;
GALLE, PR ;
STEMLER, M ;
BRUNETTO, M ;
BONINO, F ;
WILL, H .
VIROLOGY, 1993, 194 (01) :137-148
[9]  
FUANG AS, 1977, COMPREHENSIVE VIROLO, V10, P73
[10]   TARGETING OF THE HEPATITIS-B VIRUS PRECORE PROTEIN TO THE ENDOPLASMIC-RETICULUM MEMBRANE - AFTER SIGNAL PEPTIDE CLEAVAGE TRANSLOCATION CAN BE ABORTED AND THE PRODUCT RELEASED INTO THE CYTOPLASM [J].
GARCIA, PD ;
OU, JH ;
RUTTER, WJ ;
WALTER, P .
JOURNAL OF CELL BIOLOGY, 1988, 106 (04) :1093-1104